Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole cell engineering reconstructing complex molecules in yeast to bring to market next generation plant inspired medicines. Antheia’s team of scientists and technologists is headquartered in Menlo Park, California. For more information, visit www.antheia.bio.
$12M sweet spot round size
2015
$12M
from 1 investors over 1 rounds
Antheia, Inc. raised $12M on January 3, 2025
Investors: U.S. Department of Health & Human Services